Frida Bugge Bugge Askeland, MD^1,2*, Einar Haukås, MD^3*, Tobias S. S. Slørdahl, MD, PhD⁴, Anja Klostergaard, MD^5*, Tatjana Alexandersen^1*, Anna Lysén, PhD^6*, Pegah Abdollahi, PhD^1*, Emil Hermansen, MD, PhD^7* and Fredrik Schjesvold, MD, PhD¹

¹Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway
²Institute of Clinical Medicine, University of Oslo, Oslo, Norway
³Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
⁴Department of Hematology, St. Olavs University Hospital, Trondheim, Norway
⁵Department of Hematology, Aarhus University Hospital, Aarhus N, Denmark
⁶Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
⁷Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Meral Beksac, MD¹, Esther Gonzalez Garcia, MD, PhD^2*, Sosana Delimpasi, MD^3*, Pawel Robak, MD, PhD^4*, Kamaraj Karunanithi, MD^5*, Felipe De Arriba, MD, PhD^6*, Jakub Radocha, MD, PhD^7*, Kihyun Kim, MD^8*, Sergey Voloshin, MD, PhD^9*, Vera Zherebtsova, MD^10*, Iurii Osipov, MD^11*, Maria-Victoria Mateos, MD, PhD¹², Syed F. Zafar, MD¹³, Luděk Pour, MD^14*, Ivan Spicka, CSc^15*, Kazuhito Suzuki, MD, PhD¹⁶, Xin Du^17*, Jodie Wilkes, MSc^18*, Brijesh Maroj^19*, Kristin Morris, PharmD^20*, Jie Ma, PhD²¹, Margaret Polinkovsky^22*, Zhaohui Wang, MS^22*, Xiaoou L Zhou, MD, PhD^21*, Giulia Fulci, PhD^21*, Neal Sule, MBBS, MD, MSc^23*, Brandon Kremer, MD, PhD^23*, Joanna Opalinska, MD, PhD²³, Suzanne Trudel, MD^24* and Meletios A. Dimopoulos, MD²⁵

¹Department of Hematology, Ankara Liv Hospital, Istinye University, Ankara, Turkey
²Hematology, University Hospital Cabueñes, Gijón, Spain
³Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁴Medical University of Lodz, Lodz, Poland
⁵Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom
⁶Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
⁷4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University Czech Republic, Hradec Kralove, Czech Republic
⁸Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁹FMBA, Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russian Federation
¹⁰Gorodskaya Klinicheskaya Bol’nitsa Im. S.p. Botkina, Moscow, Russian Federation
¹¹Almazov National Medical Research Center, St. Petersburg, Russian Federation
¹²Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
¹³Florida Cancer Specialists & Research Institute, Fort Myers, FL
¹⁴Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
¹⁵1st Medical Department – Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Prague, Czech Republic
¹⁶Division of Clinical Oncology/ Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
¹⁷Department of Hematology, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
¹⁸GSK, Stevenage, United Kingdom
¹⁹GSK, London, United Kingdom
²⁰GSK, Durham, NC
²¹GSK, Waltham, MA
²²GSK, Upper Providence, PA
²³GSK, Collegeville, PA
²⁴Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Canada
²⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Michel Delforge^1*, Joshua Richter, MD², Yael C. Cohen³, Paolo Corradini, MD⁴, Douglas W Sborov, MD⁵, Alexander M. Lesokhin, MD⁶, Jesus G Berdeja, MD⁷, Moshe E Gatt, MD⁸, Laura Paris, MD^9*, Laura Rosinol Dachs, MD PhD^10*, Hang Quach, MD, FRACP, FRCPA, MBBS¹¹, Manisha Kanwar^12*, Olivier Catalani^13*, Paresh Sewpaul^12*, Elisabeth Wassner-Fritsch^13*, Ameet Mishra^14*, Kerstin Trunzer^13* and Shaji Kumar, MD¹⁵

¹University Hospital Leuven, Leuven, Belgium
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Sourasky Medical Center and Tel Aviv University, Tel Aviv, Israel
⁴Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy
⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN
⁸Hadassah Medical Center and Hebrew University of Jerusalem, Jerusalem, Israel
⁹Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
¹⁰Hospital Clinic de Barcelona and Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
¹¹St Vincent’s Hospital Melbourne and University of Melbourne, Melbourne, VIC, Australia
¹²Roche Products Ltd, Welwyn, United Kingdom
¹³F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵Mayo Clinic, Rochester, MN

Meral Beksac, MD¹, Simona Iacobelli^2*, Luuk Gras^3*, Linda Koster^4*, Laurien Baaij^4*, Nada Hamad, MBBS, MSc, BSc⁵, Anita D'Souza, MD⁶, Noel Estrada-Merly, MS^7*, Parameswaran N. Hari, MD, MBBS⁸, Andrew J. Cowan, MD⁹, Wael Saber, MD, MS¹⁰, Minako Iida, MD, PhD^11*, Shinichiro Okamoto^12*, Hiroyuki Takamatsu, MD, PhD¹³, Shohei Mizuno, MD, PhD^14*, Koji Kawamura, MD, PhD^15*, Yoshihisa Kodera, MD^16*, Bor-Sheng Ko, M.D. Ph.D.¹⁷, Christopher Liam, MRCP^18*, KIM Wah HO, MBBS, MRCP^19*, A Sim Goh, MD^20*, S Keat Tan^21*, Alaa M. Elhaddad, MD²², Ali Bazarbachi, MD, PhD²³, Qamar-un-Nisa Chaudhry^24*, Rozan Alfar^25*, Mohamed Amine Bekadja^26*, Malek Benakli, MD^27*, Cristobal Augusto Frutos Ortiz, MD^28*, Eloisa Riva, MD, MEd²⁹, Sebastian Galeano, MD³⁰, Francisca Bass, MD^31*, Hira Mian, MD³², Arleigh McCurdy, MD³³, Feng Rong Wang^34*, Meng Lv, MD, PhD³⁵, Daniel Neumann^36*, Mickey Boon Chai Koh, MD, PhD^37*, John Snowden, MD^38*, Stefan O. Schönland, MD^39*, Donal P McLornan, MD, PhD^40*, Patrick J Hayden, MD, PhD^41*, Damiano Rondelli, MD^42*, Hildegard Greinix^43*, Mahmoud Aljurf^44*, Yoshiko Atsuta^45*, Ana Sureda Balari⁴⁶, Dietger W. Niederwieser, MD⁴⁷ and Laurent Garderet, MD, PhD^48*

¹Hematology, Istinye University Ankara Liv Hospital, Ankara, Turkey
²Centro Di Biostatistica E Bioinformatica Università Tor Vergata, Rome, ITA
³EBMT, Leiden, Netherlands
⁴EBMT Leiden Study Unit, Leiden, Netherlands
⁵School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
⁶Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁷BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸The Medical College of Wisconsin, Brookfield, WI
⁹University of Washington, Seattle, WA
¹⁰Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹¹Aichi Medical University School of Medicine, Nagakute-cho, Aichi, JPN
¹²Keio University School of Medicine, Tokyo, JPN
¹³Department of Hematology, Kanazawa University, Kanazawa, Japan
¹⁴Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi, Japan
¹⁵Division of Hematology and Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Japan
¹⁶Aichi Medical University, Nagakute, AIC, JPN
¹⁷Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
¹⁸Hospital Sultanah Aminah, Johor Bahru, Malaysia
¹⁹Hospital Ampang, Ampang, Malaysia
²⁰Penang General Hospital, Penang, Malaysia
²¹Hospital Pulau Pinang, Pulau Pinang, Malaysia
²²Children Cancer Hospital Egypt - 57357, Cairo, Egypt
²³American University of Beirut Dept. of Medicine, Beirut, Lebanon
²⁴AFBMTC/NIBMT, Rawalpindi, Pakistan
²⁵King Hussein Cancer Center, Amman, Jordan
²⁶EHU, Oran, Algeria
²⁷Pierre and Marie Curie Center, Algiers, Algeria
²⁸25Hospital Central Del Instituto De Prevision Social, Asuncion, Paraguay
²⁹Hematology, Hospital de Clinicas, Montevideo, Uruguay
³⁰Bone marrow transplant unit, British Hospital, Montevideo, Montevideo, Uruguay
³¹Intensive Hematology Unit, Hospital Del Salvador, Santiago, Chile
³²McMaster University, Hamilton, ON, Canada
³³The Ottawa Hospital, Ottawa, ON, Canada
³⁴Peking University, Peking, China
³⁵Peking University People's Hospital, Beijing, China
³⁶IMISE, university of Leipzig, Leipzig, Germany
³⁷St George's University Hospitals, London, United Kingdom
³⁸BSBMTCT, Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
³⁹Medical Department V, Amyloidosis Center,, University of Heidelberg, Heidelberg, Germany
⁴⁰Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom
⁴¹Trinity College Dublin, St. James's Hospital, Dublin, IRL
⁴²Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
⁴³Medical University of Graz, Graz, Austria
⁴⁴Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁴⁵41Japanese Data Center for Hematopoietic Cell Transplantation, Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
⁴⁶Instituto Catalán de Oncología - Hospital Duran i Reynals, Barcelona, Spain
⁴⁷Universitaetsklinikum Leipzig Aor, Leipzig, Germany
⁴⁸Department of Hematology, Hopital Saint Antoine, Paris, FRA

Niels W.C.J. van de Donk, MD, PhD^1*, Ajai Chari, MD², Lionel Karlin^3*, Amrita Y Krishnan, MD, FACP⁴, Katarina Uttervall^5*, Thomas Chalopin, MD^6*, Laura Rosinol Dachs, MD, PhD^7*, Albert Oriol^8*, Jeffrey V Matous, MD⁹, Manisha Bhutani, MD¹⁰, Cesar Rodriguez, MD^11*, Natalia A Quijano Cardé^12*, Yue Guo, PhD^12*, Caroline Hodin^13*, Clarissa Uhlar^12*, Tara Stephenson, PhD^12*, Athena Zuppa, MD^14*, Margaret Doyle¹⁵, Katherine Chastain, MD¹⁴ and Alfred L Garfall^16*

¹Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²University of California, San Francisco, San Francisco, CA
³Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁴City of Hope Comprehensive Cancer Center, Duarte, CA
⁵Karolinska University Hospital, Stockholm, Sweden
⁶Centre Hospitalier Universitaire de Tours, Tours, France
⁷Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain
⁸Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Baldona, Barcelona, Spain
⁹Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
¹⁰Atrium Health Levine Cancer Institute/Wake Forest School of Medicine, Charlotte, NC
¹¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹²Janssen Research & Development, Spring House, PA
¹³Janssen Research & Development, Beerse, Belgium
¹⁴Janssen Research & Development, Raritan, NJ
¹⁵Janssen Global Services, Dublin, Ireland
¹⁶Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Benjamin O Adegbite, MD^1*, Carlyn Rose Tan, MD^2,3, Tala Shekarkhand, MS^3*, Ross S Firestone, MD, PhD³, Eric M Jurgens, MD³, Kevin Miller, MD^3*, Alexander M. Lesokhin, MD⁴, Gunjan L. Shah, MD⁵, Neha Korde, MD³, Sridevi Rajeeve, MD², David J. Chung, MD, PhD⁶, Heather J. Landau, MD⁷, Michael Scordo, MD⁸, Hani Hassoun, MD³, Kylee H Maclachlan, PhD, BSc, FRACP, FRCPA³, Urvi A. Shah, MD², Malin Hultcrantz, MD⁵, Issam S. Hamadeh, Pharm.D.⁹, Sergio Giralt, MD⁵, Sham Mailankody, MD, MBBS³, Saad Z. Usmani, MD⁵ and Hamza Sloan Hashmi, MD^3*

¹Mount Sinai Morningside/West, Bronx, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Myeloma & Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
⁹Clinical Pharmacy Services, Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY

Ling Qin^1*, Yuping Zhong^2*, Dongping Huang, MD, PhD^3*, Haitang Xie^3*, Xin Du^4*, Aijun Liao^5*, Hongli Zhang^6*, Shengli (Charles) Cai, MD, PhD⁶ and Jin Lu^7*

¹The First Affiliated Hospital of Henan University of Science & Technology, Henan, China
²Qingdao Municipal Hospital, Qingdao, China
³The First Affiliated Hospital of Wannan Medical College, Wuhu, China
⁴Department of Hematology, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
⁵Shengjing Hospital of China Medical University, Shenyang, China
⁶Nanjing Leads BiolabsCo., Ltd., Nanjing, China
⁷National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Beijing, China

Krina K. Patel, MD, MSc¹, Elisabet E. Manasanch, MD^2*, Hans C. Lee, MD³, J Christine Ye, MD, MSc³, Sheeba K. Thomas, MD¹, Donna M. Weber, MD³, Melody R. Becnel, MD³, Mahmoud R. Gaballa, MD³, Hima Bansal, PhD^3*, Zuzana Berkova, PhD^3*, Sattva S. Neelapu, MD³, Cara L Haymaker, PhD^4*, Minghao Dang, PhD^5*, Linghua Wang, MD, PhD, MS^5*, Greg Lizee, PhD^6* and Robert Z. Orlowski, MD, PhD³

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²GSK, Upper Providence, PA
³Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Melanoma Onco Research, The University of Texas MD Anderson Cancer Center, Houston, TX

H. Miles Prince, MD, MBBS¹, Nizar J. Bahlis, MD², Paula Rodríguez-Otero, MD, PhD^3*, Lionel Karlin^4*, Luke Akard^5*, Asya Varshavsky-Yanovsky^6*, Michael P. Chu, MD⁷, Yuya Nagai^8*, David H. Vesole, MD, PhD⁹, Anne Hickman^10*, Sharon T. Sullivan^11*, Eric Leip^11*, Umberto Conte^12*, Andrea Viqueira^13* and Alexander M. Lesokhin, MD¹⁴

¹Epworth HealthCare and University of Melbourne, Melbourne, VIC, Australia
²Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
³Clinica Universidad de Navarra, Madrid, Spain
⁴Department of Hematology, Lyon Sud Hospital, Pierre-Bénite, France
⁵Indiana Blood and Marrow Transplantation Clinic, Indianapolis, IN
⁶Fox Chase Cancer Center, Philadelphia, PA
⁷Department of Oncology, University of Alberta, Edmonton, AB, Canada
⁸Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
⁹John Theurer Cancer Center, Hackensack, NJ
¹⁰Pfizer Inc, Groton, CT
¹¹Pfizer Inc, Cambridge, MA
¹²Pfizer Inc, New York, NY
¹³Pfizer SLU, Madrid, Spain
¹⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Febe Smits, MD^1,2,3*, Kaz Groen, MD^1,2*, Mark-David Levin⁴, Claudia A M Stege, MD, PhD^5*, Roel JW van Kampen, MD PhD⁶, Ellen Van Der Spek, MD, PhD^7*, Yavuz M. Bilgin, MD PhD^8*, Noortje Thielen^9*, Inger S. Nijhof, MD, PhD^10*, Inge Ludwig, MD, MSc^11*, Esther G.M. De Waal, MD^12*, Yorick Sandberg, MD PhD^13*, Alain Kentos, MD^14*, Gert Jan Timmers, MD, PhD^15*, Josien C Regelink, MD^16*, Matthijs Westerman, MD^17*, Koen de Heer, MD, PhD^18*, Marie Christiane Vekemans, MD^19*, Nazik Durdu-Rayman, MD, PhD^20*, Nicole de Graauw, MD, PhD^21*, Maarten R. Seefat, MD^1,2*, Niels W.C.J. van de Donk, MD, PhD^1,2*, Paula F Ypma, MD, PhD^3*, Kazem Nasserinejad, PhD^22,23* and Sonja Zweegman, MD, PhD^1,2

¹Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands
³Department of Hematology, HagaZiekenhuis, The Hague, Netherlands
⁴Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
⁵Department of Hematology, Erasmus Medical Center, Rotterdam, Netherlands
⁶Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, Netherlands
⁷Department of Internal Medicine, Rijnstate Hospital, Arnhem, Netherlands
⁸Department of Internal Medicine, Adrz, Goes, Netherlands
⁹Department of Internal Medicine, Diakonessenhuis, Utrecht, Netherlands
¹⁰Department of Hematology, St Antonius Hospital, Nieuwegein, Netherlands
¹¹Department of Hematology, Bernhoven Hospital, Uden, Netherlands
¹²Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, Netherlands
¹³Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
¹⁴Department of Hematology, Jolimont Hospital, Haine Saint Paul, Belgium
¹⁵Department of Internal Medicine, Amstelland Hospital, Amstelveen, Netherlands
¹⁶Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands
¹⁷Department of Internal Medicine, Northwest Clinics, Alkmaar, Netherlands
¹⁸Department of Internal Medicine, Flevoziekenhuis, Almere, Netherlands
¹⁹Department of Hematology, Saint-Luc Hospital, Brussels, Belgium
²⁰Department of Internal Medicine, Franciscus Hospital, Schiedam, Netherlands
²¹Department of Internal Medicine, Bravis Hospital, Roosendaal, Netherlands
²²Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
²³HOVON foundation, Rotterdam, Netherlands

Filip Ionescu, MD, MS¹, Shrinjaya B Thapa, MD², Parth C Patel, DO, MS¹, Dimitrios Drekolias, MD^1*, Ariosto Siqueira Silva, PhD^1*, Praneeth R Sudalagunta, PhD^1*, Phaedra Agius^1*, Brandon Blue³, Doris K. Hansen, MD^1*, Omar Castaneda, MD⁴, Hien Liu, MD¹, Jose L. Ochoa-Bayona, MD^1*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁴, Frederick Locke, MD¹, Taiga Nishihori, MD¹, Melissa Alsina, MD¹, Kenneth H. Shain, MD, PhD⁵, Rachid Baz, MD¹ and Ariel Grajales-Cruz, MD¹

¹Moffitt Cancer Center, Tampa, FL
²Moffitt Cancer Center, Lutz, FL
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵H. Lee Moffitt Cancer Center, Tampa, FL

Leyla O. Shune, MD¹, Ayman Qasrawi, MD², Gerhard C Hildebrandt, MD³, Eric J Huselton, MD^4*, Howard Langstein, MD^5*, Dennis Allin^6*, Kaitlyn Burrows^7*, Andrea M Baran, MS^8*, Jane L. Liesveld, MD⁹, Neil Blumberg, MD¹⁰, Brea Lipe, MD¹¹, Andrew G Evans, MD, PhD^12*, Derick R Peterson, PhD^8* and Omar Aljitawi, MD¹³

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Westwood, KS
²University of Kentucky, Lexington, KY
³Department of Medicine, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO
⁴James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
⁵University of Rochester, Rochester, NY
⁶University of Kansas, Lenexa, KS
⁷Wilmot Cancer Institute, The University of Rochester Medical Center, Rochester
⁸Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY
⁹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
¹⁰Division of Transfusion Medicine, Pathology and Laboratory Medicine, University Of Rochester Medical Center, Rochester, NY
¹¹University of Rochester Medical Center, Rochester, NY
¹²Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
¹³James P. Wilmot Cancer Center, University of Kansas Medical Center, Rochester, NY

Rachel Dileo^1,2*, Prerna Mewawalla, MD^2,3*, Gina Patrus^1,2*, Christopher Strouse, MD^2,4, Ethan Chen, MD^2,5*, Hira Shaikh, MD^2,4, James A Davis, PharmD^2,6*, Kimberly M Green, DO^2,6*, Omar Alkharabsheh, MBBS^2,7, Aliya Rashid, DO, MPH^2,8, Bidushi Pokhrel^9*, Nausheen Ahmed, MD^2,9, Al-Ola Abdallah, MD^2,10 and Hamza Sloan Hashmi, MD^2,11,12*

¹Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Allegheny Health Network, Pittsburgh, PA
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁵Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
⁶Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁷University of South Alabama Mitchell Cancer Institute, Mobile, AL
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC

Matthew Pianko¹, Charlotte Pawlyn, PhD², Shang-Yi Huang, MD, PhD^3*, Tadao Ishida⁴, Douglas W Sborov, MD⁵, Shinsuke Iida, MD, PhD⁶, Aravind Ramakrishnan, MD⁷, Reuben Benjamin^8*, Rakesh Popat⁹, Steven Schuster¹⁰, Junya Kuroda, MD, PhD¹¹, Chia-Jen Liu^12*, Anne Philippe^13*, Umberto Conte^14*, Fangxin Hong¹⁵, Erik Vandendries¹⁵ and Rafael Fonseca, MD¹⁶

¹Rogel Cancer Center, University of Michigan, Ann Arbor, MI
²Institute of Cancer Research, Sutton, United Kingdom
³Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁴Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁶Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
⁷St. David’s South Austin Medical Center, Austin, TX
⁸King's College Hospital, London, United Kingdom
⁹NIHR/University College London Hospital Clinical Research Facility, NHS Foundation Trust, London, United Kingdom
¹⁰UCHealth Cancer Care and Hematology, Fort Collins, CO
¹¹Division of Hematology and Oncology, Department of Medicine,, Kyoto Prefectural University of Medicine, Kyoto, Japan
¹²Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
¹³Pfizer Inc, Paris, France
¹⁴Pfizer Inc, New York, NY
¹⁵Pfizer Inc, Cambridge, MA
¹⁶Division of Hematology, Mayo Clinic, Paradise Valley, AZ

Ceri Bygrave, MBBCh MRCP FRCPath^1,2*, William Wilson, PhD^3*, Rakesh Popat^4,5, Marquita Camilleri, MD^6*, Karthik Ramasamy, MD, PhD^7,8,9, Matthew Streetly^10*, Michael A. Chapman, PhD^11,12, Ruth M de Tute, MSc, PhD, FRCPath^13*, Selina J Chavda, MBBS, BSc, MRCP^14*, Elizabeth H. Phillips^15,16*, Maria del Mar Cuadrado^17*, Fuad Fananapazir^17*, Charlotte Tyson^18*, Sumaiya Kamora^18*, James D. Cavenagh, MD¹⁹, Roger G Owen, MD, MRCP, FRCPath^13* and Kwee Yong, MD, PhD^20,21

¹Department of Haematology, Cardiff University, Cardiff, United Kingdom
²Department of Haematology, Cardiff & Vale University Health Board, Cardiff, United Kingdom
³Cancer Research UK & UCL Cancer Trials Centre, University College London Cancer Institute, London, United Kingdom
⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Research department of Haematology, University College London Cancer Institute, London, United Kingdom
⁶Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom
⁷University of Oxford, Oxford, ENG, United Kingdom
⁸Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁹Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom
¹⁰Guy's and St Thomas' Hospital, London, United Kingdom
¹¹Department of Haematology, University of Cambridge, Cambridge, United Kingdom
¹²MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
¹³HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁴University College London, London, GBR
¹⁵University of Manchester, Christie NHS Foundation Trust and Division of Cancer Sciences, Manchester, United Kingdom
¹⁶Division of Cancer Sciences, University of Manchester, University of Manchester, Manchester, United Kingdom
¹⁷UCL Cancer Institute, London, United Kingdom
¹⁸Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom
¹⁹Department of Haematology, St. Bartholomew's Hospital, London, GBR
²⁰UCL Cancer Institute, University College London, London, United Kingdom
²¹University College London, London, United Kingdom

Jakob Nordberg Nørgaard, MD^1,2*, Anna Lysén, PhD^2,3*, Galina Tsykunova, MD^4*, Annette Vangsted^5*, Cristina João, MD, MsC, PhD^6*, Nora Remen^2*, Lene Kongsgaard Nielsen, MD, PhD^7,8*, Caroline Stokke, PhD^9*, James P Connelly^10*, Mona-Elisabeth R. Revheim^11,12* and Fredrik Schjesvold, MD, PhD^13,14

¹University of Oslo, KG Jebsen Center for B-cell Malignancies, Oslo, Norway
²Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
³University of Oslo, KG Jebsen Center for B-Cell Malignancies, Oslo, Norway
⁴Division of Hematology, Haukeland University Hospital, Bergen, Norway
⁵Rigshospitalet, Copenhagen, Denmark
⁶Champalimaud Foundation, Lisbon, Portugal
⁷Department of Hematology, Gødstrup Hospital, Herning, Denmark
⁸Quality of Life Research Center, Department of Hematology, Odense University Hospital, Odense, Denmark
⁹Oslo University Hospital, Division for Radiology and Nuclear Medicine, Oslo, NOR
¹⁰Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, NOR
¹¹University of Oslo, Institute of Clinical Medicine, Oslo, Norway
¹²Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
¹³Oslo University Hospital, Oslo Myeloma Center, Oslo, Norway
¹⁴KG Jebsen Center for B cell malignancies, Institute of clinical medicine, University of Oslo, Oslo, Norway

Ying Tian^1*, Keshu Zhou^2*, Quande Lin^2*, Wenbin Qian^3*, Wei Yang^4*, Li Bao^5*, Guolin Yuan^6*, Xiaojing Yan⁷, Liangming Ma^8*, Xin Zhou^9*, Lihong Liu^10*, Fangbing Zhu^11*, Xuelan Zuo^12*, Xin Du^13*, Xu Ji^2*, Xuzhao Zhang^3*, Jing Shen^4*, Hai Zhou^14*, Na Li^15* and Wenming Chen^1*

¹Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
²Department of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
³Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
⁴Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
⁵Department of Hematology, Beijing JiShuiTan Hospital, Beijing, China
⁶Xiangyang Central Hospital, the Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
⁷The First Hospital of China Medical University, Shenyang, China
⁸Department of Hematology, Shanxi Bethune Hospital, Taiyuan, China
⁹Department of Hematology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China
¹⁰Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital, Shijiazhuang, China
¹¹Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
¹²Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China
¹³Department of Hematology, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
¹⁴Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
¹⁵Department of Clinical Development, Hangzhou Sumgen Biotech Co., Ltd., Beijing, China

Elizabeth K. O'Donnell, MD¹, Clifton C. Mo, MD², Omar Nadeem, MD³, Jacob Laubach⁴, Jacalyn Rosenblatt, MD⁵, Nikhil C. Munshi, MD², Shonali Midha, MD^6*, Diana Cirstea, MD^7*, Paul G. Richardson², Noopur Raje⁸ and Andrew J. Yee, MD⁹

¹Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA
⁵Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
⁶Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA
⁸Massachusetts General Hospital, Boston, MA
⁹Massachusetts General Hospital Cancer Center, Boston, MA

Jin Lu, MD, PhD^1*, Liangquan Geng, MD, PhD^2*, Lijuan Chen^3*, Peng Liu, MD⁴, Yuping Zhong, MD, PhD^5*, Zhuogang Liu^6*, Zhongjun Xia, MD, PhD⁷, Jianqing Mi, MD, PhD^8*, Chunrui Li, MD, PhD⁹, Xi Zhang, PhD¹⁰, Yanjuan He^11*, Yongqiang Wei, MD^12*, Baijun Fang^13*, Fei Li¹⁴, Zhen Cai^15*, Yafei Wang^16*, Dongping Huang, MD, PhD^17*, Hong Liu^18*, Ming Hou^19*, Rong Fu^20*, Xin Du^21*, Xiaosheng Fang^22*, Qingshu Zeng^23*, Wen Gao²⁴, Wei Wang^25*, Chunkang Chang^26*, Guifang Ouyang^27*, Jing Liu, PhD^28*, Jianyu Weng, MD, PhD^29*, Xiaobing Huang, MD, PhD^30*, Yang Yu^31*, Zhi Guo^31*, Jun Zhao^31* and Jian Hou^32*

¹Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology, Beijing, China
²First Affiliated Hospital of University of Science and Technology of China (USTC) Anhui Provincial Hospital, Hefei, China
³Jiangsu Province Hospital, Nanjing, CHN
⁴Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
⁵Qingdao Municipal Hospital, Qingdao, China
⁶Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
⁷State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁸Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁰Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China
¹¹Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
¹²Nanfang Hospital of Southern Medical University, Guangzhou, China
¹³Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Henan, China
¹⁴Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
¹⁵The First Affiliated Hospital of Zhejiang University Medical College, Zhejiang, China
¹⁶Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹⁷The First Affiliated Hospital of Wannan Medical College, Wuhu, China
¹⁸Affiliated Hospital of Nantong University, Nantong, China
¹⁹Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
²⁰Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
²¹Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
²²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
²³Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
²⁴Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
²⁵Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China
²⁶People's Hospital of Shanghai, Shanghai, China
²⁷The First Affiliated Hospital of Ningbo University, Ningbo, China
²⁸Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
²⁹Guangdong Provincial People's Hospital, Guangdong, China
³⁰Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
³¹Antengene Therapeutics Ltd., Shanghai, China
³²Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Jeffrey V Matous, MD¹, Niels W.C.J. van de Donk, MD, PhD^2*, Albert Oriol^3*, Alfred L. Garfall, MD⁴, Paula Rodríguez-Otero, MD, PhD^5*, Thomas Chalopin, MD^6*, Laura Rosinol Dachs, MD PhD^7,8*, Katarina Uttervall^9*, Maria- Victoria Mateos¹⁰, Danielle Trancucci^11*, Natalia Quijano Cardé^12*, Caroline Hodin^13*, Tara Stephenson, PhD^12*, Athena Zuppa, MD^11*, Katherine Chastain, MD¹¹ and Lionel Karlin^14*

¹Colorado Blood Cancer Institute, Denver, CO
²Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
³Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Baldona, Barcelona, Spain
⁴Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Department of Hematology, Cancer Center Clínica Universidad de Navarra, Pamplona, Navarra, Spain
⁶Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, Tours, Centre Val de Loire, France
⁷Hematopoietic Cell Transplant Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
⁸Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain
⁹Hematology Medical Unit, Karolinska University Hospital, Stockholm, Sweden
¹⁰Salamanca/Instituto de Investigacio´ n Biome´ dica de Salamanca/Centre for Cancer Research Institute of Cancer Molecular and Cellular Biology, Salamanca, Spain
¹¹Janssen Research & Development, Raritan, NJ
¹²Janssen Research & Development, Spring House, PA
¹³Janssen Research & Development, Beerse, Belgium
¹⁴Department of Hematology, Lyon Sud Hospital, Pierre-Bénite, France

Lingzhi Yan^1*, Xiaolan Shi^1*, Jing Wang^2*, Song Jin^1*, Ying Yao^2*, Panfeng Wang^2*, Jingjing Shang^1*, Yingying Zhai^1*, Shuang Yan^1*, Yun Xu^2*, Jiajia Meng^2*, Weiqin Yao^1*, Xiao Ma^1*, Chengcheng Fu^1* and Depei Wu, MD, PhD¹

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Soochow Hopes Hematonosis Hospital, Suzhou, China

Shebli Atrash, MD¹, James Symanowski^2*, Sarah Norek^3*, Monica Plott^4*, Cecilia Flynn^4*, Kelly Bumgarner^4*, Darynne Rhinehardt^4*, Xhevahire Begic^3*, Robin Cox^4*, Barry Paul, MD, MS¹, Cindy Varga, MD, BSc⁵, Reed Friend, MD⁶, Christopher Ferreri, MD⁷, Manisha Bhutani, MD⁸, Mauricio Pineda-Roman^6* and Peter M. Voorhees, MD⁶

¹Levine Cancer Institute, Charlotte, NC
²Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
³Sponsored Research Coordinating Center, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Levine Cancer Institute, Charlotte
⁵Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁶Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁷Atrium Health Levine Cancer Institute, Charlotte, NC
⁸Levine Cancer Institute, Atrium Health, Charlotte, NC

Steven Shih, MBBS¹, Elizabeth Thatcher^1*, Henry Chan, MD^1*, Amelia Turnwald^1*, Sophie Leitch^1*, Rajeev Rajagopal^2* and David Simpson, FRACP, FRCPA¹

¹Haematology Service, Health New Zealand - Te Whatu Ora - Waitemata, Auckland, New Zealand
²Haematology Service, Health New Zealand - Te Whatu Ora - Counties Manukau, Auckland, New Zealand

Robert Rifkin, MD, FACP¹, Henning Schade, MD^2*, Gary Simmons, DO, MSHA^3*, Christopher Yasenchak, MD⁴, Jessica Fowler, PhD^5*, Thomas S. Lin, MD, PhD⁶, Lijuan Kang, PhD^7* and Weiming Xu, MD, PhD^8*

¹Rocky Mountain Cancer Centers - Denver – Midtown, Denver, CO
²Colorado Blood Cancer Institute, Denver, CO
³US Oncology, Norfolk, VA
⁴Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
⁵Janssen Scientific Affairs, Horsham, PA, Horsham, PA
⁶Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA
⁷Janssen Research & Development, Spring House, PA
⁸Sarah Cannon Research Institute, Nashville, TN

Udit Nangia, MD¹, Deepak Chandramohan, MD^2*, Hari Naga Garapati, MD^3*, Prathap Simhadri, MD^4* and Neeraj Mahajan, MD^5*

¹University Hospitals - Parma Medical Center, Vernon Hills, IL
²The University of Alabama at Birmingham, Birmingham, AL
³Baptist Medical Center South, Montgomery, AL
⁴AdventHealth East Florida, Daytona Beach, FL
⁵University Hospitals - Parma Medical Center, Parma, OH

Sueh-Li Lim, MBBS, FRACP, FRCPA^1,2, John Reynolds, BSc, MSc, PhD^1,2*, Lucy Pemberton, BMBS MD MRCP FRCPath FRCPA^3*, Tricia Wright, BS, FRACP, FRCP, MBBS^4*, Sophie Hyesuk Lee, MBChB PhD FRCPA FRACP^5*, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁶, Anita C Shetty, MD^7*, Helen Weston, BMBS FRCPA FRACP^8*, Nina Byard, BSW^9*, Khoa Le, BPharm^9*, Zoe K McQuilten, MBBS, PhD¹⁰, Hang Quach, MD, FRACP, FRCPA, MBBS¹¹ and Andrew Spencer, MBBS, DM (Lond), FRACP, FRCPA^1,2*

¹Department of Malignant Haematology, Transplantation and Cellular Therapy Services, Alfred Health, Melbourne, Australia
²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
³Southern Blood and Cancer Service, Dunedin Hospital, Dunedin, New Zealand
⁴Latrobe Regional Hospital, Traralgon, Victoria, AUS
⁵Western Health, Melbourne, Australia
⁶Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁷Nepean Hospital, Penrith, Australia
⁸Sunshine Coast University Hospital, Queensland, Australia
⁹Australasian Myeloma Research Consortium, Alfred Health, Melbourne, Australia
¹⁰Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹¹St. Vincent's Hospital Melbourne, East Melbourne, Australia

Jill Corre, PharmD, PhD^1*, Jérôme Lambert, MD, PhD^2*, Arthur Bobin^3*, Salomon Manier^4*, Aurore Perrot, MD, PhD^5,6, Lionel Karlin^7*, Murielle Roussel, MD^8*, Noemie Bigot^9*, Omar Benbrahim, MD^10*, Olivier Thierry Allangba, MD^11*, Philippe Rey^12*, Veronique Dorvaux^13*, Marguerite Vignon, MD^14*, Virginie Roland^15*, Reda Garidi^16*, Jean-Noel Bastie^17*, Marie-Lorraine Chrétien, MD^18*, Sophie Godet^19*, Lydia Montes, MD^20*, Brieuc Cherel^21*, Thomas Chalopin, MD^22*, Borhane Slama, MD^23*, Kamel Laribi^24*, Claire Dingremont^25*, Christophe Roul^26*, Valentine Richez^27*, Clara Mariette^28*, Sophie Rigaudeau, MD^29*, Claire Calmettes^30*, Mamoun Dib^31*, Mourad Tiab, MD^32*, Laure Vincent, MD^33*, Jacques Delaunay^34*, Jean Pierre Marolleau, MD³⁵, Pascal Godmer^36*, Laurent Frenzel, MD, PhD^37*, Ronan Le Calloch^38*, Emilie Chalayer, MD, PhD^39*, Helene Gardeney, MD^40*, Margaret Macro, MD^41*, Bruno Royer, MD^42*, Olivier Decaux, MD, PhD^43*, Bertrand Arnulf, MD⁴⁴, Karim Belhadj Merzoug, MD, PhD^45*, Cyrille Touzeau, MD, PhD^46*, Mohamad Mohty^47*, Aurelie Gontier^48*, Amine Kasmi^49*, Philippe Moreau, MD, PhD^50*, Thierry Facon, MD⁵¹, Herve Avet Loiseau, MD, PhD¹, Cyrille Hulin, MD^52* and Xavier Leleu^53,54

¹Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
²Biostatistics and Medical Information Department, Saint Louis University Hospital, AP-HP, Paris, France
³Hematology department & CIC 1402, Poitiers University Hospital, Poitiers, France
⁴University of Lille, CHU Lille, Lille, France
⁵Hematologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
⁶Centre Hospitalier Universitaire de Toulouse, Service d'Hématologie, Toulouse, France
⁷Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
⁸Hématologie Clinique, CHU de Limoges, Limoges, France
⁹Biostatistics Department, Hôpital Saint Louis, APHP, Paris, France
¹⁰HOPITAL LA SOURCE, La Source, FRA
¹¹CH saint brieuc, Saint Brieuc, FRA
¹²Centre Leon Berard, Lyon, FRA
¹³Hopital De Metz Mercy, Metz, France
¹⁴Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
¹⁵CH de Perpignan, Perpignan, France
¹⁶CH Saint Quentin, Saint Quentin, FRA
¹⁷CHU Dijon, DIJON, FRA
¹⁸Hematology Department, CHU Dijon, Dijon, France
¹⁹CHU Reims, Reims, FRA
²⁰CHU Amiens-Picardie, Amiens, France
²¹CH Vannes, Vannes, France
²²Hematology, Centre hospitalier universitaire de Tours, Tours, FRA
²³Department of Hematology, Avignon Hospital Center, Avignon, France
²⁴Hématologie Clinique, CH Le Mans, Le Mans, France
²⁵Ch de Tarbes, Tarbes, FRA
²⁶CH de La Rochelle, La Rochelle, FRA
²⁷CHU Nice, Nice Cedex 3, France
²⁸CHU de Grenoble, grenoble, France
²⁹CH Versailles, Le Chesnay Rocquencourt, FRA
³⁰CH de Périgueux, Périgueux, France
³¹Chu Angers, Angers, FRA
³²Centre Hospitalier Departemental, La Roche Sur Yon Cedex 9, FRA
³³Department of Clinical Hematology, Hôpital St Eloi, CHU de Montpellier, Montpellier, France
³⁴Hôpital privé du confluent, Nantes, France
³⁵Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
³⁶CH Vannes, Vannes, FRA
³⁷Department of Haematology, Hemophilia Care and Research, Necker Hospital, Institut Imagine, Paris, France
³⁸CH Quimper, Quimper, FRA
³⁹Department of Hematology, Centre Hospitalo Universitaire de Saint-Etienne, Saint Etienne, France
⁴⁰Hematology department & CIC 1402, Poitiers University Hospital, POITIERS, France
⁴¹Hopital Cote De Nacre, Caen, France
⁴²Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France
⁴³Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes, France
⁴⁴Immuno-hematology, Saint Louis Hospital, Paris Cedex 10, France
⁴⁵Unit of Lymphoid Hemopathies, Henri Mondor Hospital, Greater Paris University Hospitals (AP-HP), Creteil, France
⁴⁶Centre Hospitalier Universitaire de Nantes, Nantes, France
⁴⁷Hopital Saint Antoine, Paris, FRA
⁴⁸CHU de Poitiers, poitiers, France
⁴⁹CHU de Poitiers, Poitiers, France
⁵⁰University Hospital Hôtel-Dieu, Nantes, France
⁵¹University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
⁵²Hôpital Haut Lévêque, University Hospital, Pessac, France
⁵³Department of Hematology, CHU Poitiers – Hôpital la Milétrie, Poitiers, France
⁵⁴Service d'Hématologie et Thérapie Cellulaire, CHU and CIC Inserm 1402, Poitiers, France

Joshua Richter, MD¹, Saulius Girnius, MD², Ruemu Birhiray³, Eric Lloyd^4*, Dasha Cherepanov^4*, Stephen J. Noga, MD, PhD⁴, Isabel Nascimento-Ferreira^4* and Robert Rifkin, MD, FACP⁵

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Trihealth Cancer Institute, Cincinnati, OH
³Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN
⁴Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA
⁵Rocky Mountain Cancer Center/US Oncology Research, Denver, CO